0001144204-15-007160.txt : 20150209 0001144204-15-007160.hdr.sgml : 20150209 20150209170816 ACCESSION NUMBER: 0001144204-15-007160 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150206 FILED AS OF DATE: 20150209 DATE AS OF CHANGE: 20150209 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Alliqua BioMedical, Inc. CENTRAL INDEX KEY: 0001054274 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 582349413 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2150 CABOT BOULEVARD WEST CITY: LANGHORNE STATE: PA ZIP: 19047 BUSINESS PHONE: 215-702-8550 MAIL ADDRESS: STREET 1: 2150 CABOT BOULEVARD WEST CITY: LANGHORNE STATE: PA ZIP: 19047 FORMER COMPANY: FORMER CONFORMED NAME: Alliqua, Inc. DATE OF NAME CHANGE: 20101222 FORMER COMPANY: FORMER CONFORMED NAME: HEPALIFE TECHNOLOGIES INC DATE OF NAME CHANGE: 20030529 FORMER COMPANY: FORMER CONFORMED NAME: ZETA CORP DATE OF NAME CHANGE: 20030219 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BARTON BRADFORD CENTRAL INDEX KEY: 0001618553 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36278 FILM NUMBER: 15589379 MAIL ADDRESS: STREET 1: C/O ALLIQUA BIOMEDICAL, INC. STREET 2: 2150 CABOT BLVD. WEST CITY: LANGHORNE STATE: PA ZIP: 19047 4 1 v400818_4.xml FORM 4 X0306 4 2015-02-06 0 0001054274 Alliqua BioMedical, Inc. ALQA 0001618553 BARTON BRADFORD C/O ALLIQUA BIOMEDICAL, INC. 2150 CABOT BLVD. WEST LANGHORNE PA 19047 0 1 0 0 Chief Operating Officer Common Stock 2015-02-06 4 A 0 100000 0 A 115210 D Stock Option (right to buy) 6.23 2015-02-06 4 A 0 115000 0 A 2025-02-06 Common Stock 115000 115000 D Represents a restricted stock award that is subject to forfeiture until vested. This award vests in three equal annual installments, with one-third (1/3rd) vesting on each of February 6, 2016, February 6, 2017 and February 6, 2018, subject to the terms and conditions of the Alliqua BioMedical, Inc. 2014 Long-Term Incentive Plan and that certain restricted stock award agreement by and between the Issuer and Mr. Barton, effective as of February 6, 2015. The option vests in three equal annual installments, with one-third (1/3rd) vesting and becoming exercisable on each of February 6, 2016, February 6, 2017 and February 6, 2018, subject to the terms and conditions of the Alliqua BioMedical, Inc. 2014 Long-Term Incentive Plan and Mr. Barton's continued service on the applicable vesting date. /s/ Bradford Barton 2015-02-09